Prospects for stem cell transplantation in the treatment of hepatic disease

Liver Transplantation

Volumn 16, Issue 7, 2010, Pages 827-836

  Stutchfield, Benjamin M ^a   Forbes, Stuart J ^a   Wigmore, Stephen J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; ADULT STEM CELL; ARTIFICIAL EMBOLISM; CELL DIFFERENTIATION; CHRONIC LIVER DISEASE; CLINICAL RESEARCH; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; LIVER RESECTION; LIVER SUPPORT; PLURIPOTENT STEM CELL; PORTAL VEIN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; CHRONIC DISEASE; CYTOLOGY; LIVER DISEASE; METHODOLOGY; PHYSIOLOGY;

ACUTE DISEASE; CELL DIFFERENTIATION; CHRONIC DISEASE; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER REGENERATION; STEM CELL TRANSPLANTATION;

EID: 77954148115     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22083     Document Type: Review

References (104)

1. Mallet VO, Gilgenkrantz H. Mobilizing stem cells to repair liver after surgery: dream or reality? J Hepatol 2005;43:754-756.
2. Masson S, Harrison DJ, Plevris JN, Newsome PN. Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells 2004;22:897-907. (Pubitemid 39507078)
3. Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, Wright NA. The new stem cell biology: something for everyone. Mol Pathol 2003;56:86-96.
4. Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008;26:1117-1127.
5. Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schormann W, et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocytelike and pancreatic islet-like cells. Gastroenterology 2005;128:177-1786.
6. Moriya K, Yoshikawa M, Ouji Y, Saito K, Nishiofuku M, Matsuda R, et al. Embryonic stem cells reduce liver fibrosis in CCl4-treated mice. Int J Exp Pathol 2008;89: 401-409.
7. am Esch JS II, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005;23:463-470.
8. Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, et al. Portal vein embolisation and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology 2007;243:171-179.
9. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, et al. Characterisation and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006;24:1822-1830.
10. Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007;13:1067-1073.
11. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24:2292-2298.
12. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
13. Kuwahara R, Kofman AV, Landis CS, Swenson ES, Barendswaard E, Theise ND. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology 2008;47:1994-2002.
14. Paku S, Schnur J, Nagy P, Thorgeirsson SS. Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol 2001;158:1313-1323. (Pubitemid 32281295)
15. Fellous TG, Islam S, Tadrous PJ, Elia G, Kocher HM, Bhattacharya S, et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology 2009;49:1655-1663.
16. Zajicek G, Oren R, Winreb M. The streaming liver. Liver 1985;5:293-300.
17. Oren R, Zajicek G, Maaravi Y, Kenet G, Karmely F, Hubert A, et al. Methimazole slows hepatocyte streaming in rats. Dig Dis Sci 1997;42:1433-1437.
18. Kennedy S, Rettinger S, Flye MW, Ponder KP. Experiments in transgenic mice show that hepatocytes are the source for postnatal liver growth and do not stream. Hepatology 1995;22:160-168.
19. Bralet MP, Branchereau S, Brechot C, Ferry N. Cell lineage study in the liver using retroviral mediated gene transfer: evidence against the streaming of hepatocytes in normal liver. Am J Pathol 1994;144:896-905. (Pubitemid 24160631)
20. Iannaconne PM, Weinberg WC, Berkwits L. A probabilistic model of mosaicism based on the histological analysis of chimaeric rat liver. Development 1987;99:187-196. (Pubitemid 17047599)
21. Terrace J, Hay DC, Samuel K, Payne C, Anderson RA, Currie IS, et al. Side population cells in developing human liver are primarily haematopoietic progenitor cells. Exp Cell Res 2009;315:2141-2153.
22. Gehling UM, Willems M, Dandri M, Petersen J, Berna M, Thill M, et al. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 2005;43:845-853.
23. Lemoli RM, Catani L, Talarico S, Loggi E, Gramenzi A, Baccarani U, et al. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells 2006;24:2817-2825.
24. Terada R, Yamamoto K, Hakoda T, Shimada N, Okano N, Baba N, et al. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 2003;83:665-672.
25. Dalakas E, Newsome P, Harrison DJ, Plevris JN. Hematopoietic stem cell trafficking in liver injury. J Fed Am Soc Exp Biol 2005;19:1225-1231.
26. Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, Dabeva MD, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003;112: 160-169.
27. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284: 143-147.
28. Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM, Krause DS. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000;31:235-240. (Pubitemid 30033713)
29. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-1234.
30. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006;43:2-8.
31. Han B, Lu Y, Meng B, Qu B. Cellular loss after allogenic hepatocyte transplantation. Transplantation 2009;87: 1-5.
32. Dan Y, Yeoh G. Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 2008;23:687-698.
33. Yamamoto H, Quinn G, Asari A, Yamanokuchi H, Teratani T, Terada M, Ochiya T. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 2003;37:983-993.
34. Deng X, Song E, Min J. Effect of intrahepatic transplantation of embryonic stem cells-derived hepatic stem cells on host hepatic function and its safety evaluation. J Clin Rehab Tissue Eng Res 2008;12:1591-1595.
35. Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M, et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 2006;44:1478-1486.
36. Oertel M, Menthena A, Chen YQ, Teisner B, Jensen CH, Shafritz DA. Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology 2008;134:823-832.
37. Haridass D, Yuan Q, Becker PD, Cantz T, Iken M, Rothe M, et al. Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promotor-enhancer urokinase-type plasminogen activator mice. Am J Pathol 2009;175:1483-1492.
38. Hay DC, Fletcher J, Payne C, Terrace JD, Gallagher RC, Snoeys J, et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signalling. Proc Natl Acad Sci U S A 2008;105:12301-12306.
39. Heng BC, Yu H, Yin Y, Lim SG, Cao T. Factors influencing stem cell differentiation into hepatic lineage in vitro. J Gastroenterol Hepatol 2005;20:975-987.
40. Teramoto K, Hara Y, Kumashiro Y, Chinzei R, Tanaka Y, Shimizu-Saito K, et al. Teratoma formation and hepatocyte differentiation in mouse liver transplanted with mouse embryonic stem cell-derived embryoid bodies. Transplant Proc 2005;37:285-286.
41. Wu DC, Boyd AS, Wood KJ. Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 2008;26:1939-1950.
42. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-2025.
43. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, Fairchild PJ, et al. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes induction of tolerance. Proc Natl Acad Sci U S A 2007;26: 20920-20925.
44. Martin MJ, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005;11:228-232.
45. King CC, Beattie GM, Lopez AD, Hayek A. Generation of definitive endoderm from human embryonic stem cells cultured in feeder layer-free conditions. Regen Med 2008;3:175-180.
46. Li W, Wang D, Qin J, Liu C, Zhang Q, Zhang X, et al. Generation of functional hepatocytes from mouse induced pluripotent stem cells. J Cell Physiol 2009; 222:492-501.
47. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, et al. Highly efficient generation of human hepatocyte- like cells from induced pluripotent stem cells. Hepatology 2010;51:297-305.
48. Sullivan GJ, Hay DC, Park IH, Fletcher J, Hannoun Z, Payne CM, et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010;51:329-355.
49. Takahashi K, Narita M, Yokura M, Ichisaka T, Yamanaka S. Human induced pluripotent stem cells on autologous feeders. PLoS One 2009;4:e8067.
50. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, et al. Isolation and characterisation of a stem cell population from adult human liver. Stem Cells 2006;24:2840-2850.
51. Campard D, Lysy PA, Najimi M, Sokal EM. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008;134:833-848.
52. Zheng YB, Gao ZL, Xie C, Zhu HP, Peng L, Chen JH, Chong YT. Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: a comparative study. Cell Biol Int 2008;32:1439-1448.
53. Ikeda E, Yagi K, Kojima M, Yagyuu T, Ohshima A, Sobajima S, et al. Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease. Differentiation 2008;76:495-505.
54. Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, Sempoux C, Sokal EM. Adult-derived human liver mesenchymal- like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 2007;16:717-728.
55. Sato Y, Araki H, Kato J. Human mesenchymal stem cells xenografted directly to rat liver and differentiated into human hepatocytes without fusion. Transplantation 2005;106:756-763.
56. di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008;57:223-231.
57. Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation 2006;82:441-449.
58. Yu CH, Chen HL, Chen YH, Chang MF, Chien CS, Chang MH. Impaired hepatocyte regeneration in acute severe hepatic injury enhances effective repopulation by transplanted hepatocytes. Cell Transplant 2009;18:1081-1092.
59. Efimova EA, Glanemann M, Nussler AK, Schumacher G, Settmacher U, Jonas S, et al. Changes in serum levels of growth factors in healthy individuals after living related liver donation. Transplant Proc 2005;37:1074-1075.
60. Kobayashi N, Ito M, Nakamura J, Cai J, Gao C, Hammel JM, Fox IJ. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 2000;31:851-857. (Pubitemid 30169930)
61. Fox IJ, Chowdhury JR. Hepatocyte transplantation. Am J Transplant 2004;4(suppl 6):7-13.
62. Yokoyama T, Ohashi K, Kuge H, Kanehiro H, Iwata H, Yamato M, Nakajima Y. In vivo engineering of metabolically active hepatic tissues in a neovascularized subcutaneous cavity. Am J Transplant 2005;6:50-59.
63. Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med 2008;12: 56-66.
64. Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, et al. Prospective, randomized, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239:660-667.
65. Chamuleau RA, Deurholt T, Hoekstra R. What are the right cells to be used in the bioartificial liver? Metab Brain Dis 2005;20:327-335.
66. Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000;406:257.
67. Theise ND, Nimmakayalu M, Gardner R, Illei PB, Morgan G, Teperman L, et al. Liver from bone marrow in humans. Hepatology 2000;32:11-16.
68. De Silvestro G, Vicarioto M, Donadel C, Menegazzo M, Marson P, Corsini A. Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology 2004;51:805-810. (Pubitemid 38590969)
69. Vassilopoulos G, Wang PR, Russel DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-904.
70. Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, Yarmush ML. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 2007;363: 247-252.
71. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004;6: 532-539.
72. Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 2004;10:744-748.
73. Chivu M, Dima SO, Stancu CI, Dobrea C, Uscatescu V, Necula LG, et al. In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors. Transl Res 2009;154:122-132.
74. Fujii H, Hirose T, Oe S, Yasuchika K, Azuma H, Fujikawa T, et al. Contribution of bone marrow derived cells to liver regeneration after partial hepatectomy in mice. J Hepatol 2002;36:653-659.
75. Beaudry P, Hida Y, Udagawa T, Alwayn IP, Greene AK, Arsenault D, et al. Endothelial progenitor cells contribute to accelerated liver regeneration. J Pediatr Surg 2007;42:1190-1198.
76. Greene AK, Wiener S, Puder M, Yoshida A, Shi B, Perez-Atayde AR, et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg 2003; 237:530-535.
77. Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005;33:108-119.
78. Kienstra KA, Jackson KA, Hirschi KK. Injury mechanism dictates contribution of bone marrow-derived cells to murine hepatic vascular regeneration. Pediatr Res 2008;63:131-136.
79. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134: 2111-2121.
80. Parekkadan B, Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007;2:e941.
81. Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X, et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine regeneration. Hepatology 2002;35:40-48.
82. Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells. J Hepatol 2006;44:742-748.
83. Natori T, Sata M, Washida M, Hirata Y, Nagai R, Makuuchi M. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun 2002;297:1058-1061.
84. Veerappan R, Morrison M, Williams S, Variakojis D. Splenic rupture in a patient with plasma cell myeloma following G0CSF/GM-CSF administration for stem cell transplantation and review of the literature. Bone Marrow Transplant 2007;40:361-364.
85. Quesenberry PJ, Dooner G, Colvin G, Abedi M. Stem cell biology and the plasticity polemic. Exp Hematol 2005;33:389-394.
86. Bonde J, Hess DA, Nolta JA. Recent advances in hematopoietic stem cell biology. Curr Opin Hematol 2004;11: 392-398.
87. Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, Eades WC, et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 2008;26:611-620.
88. Ezoe S, Matsumura I, Satoh Y, Tanaka H, Kanakura Y. Cell cycle regulation in hematopoietic stem/progenitor cells. Cell Cycle 2004;3:314-318.
89. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007;13:3359-3363. (Pubitemid 47062247)
90. Newsome PN, Johannessen I, Boyle S, Dalakas E, McAulay KA, Samuel K, et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 2003;124:1891-1900.
91. Fan TX, Hisha H, Jin TN, Yu CZ, Lian ZX, Guo SB, et al. Successful allogeneic bone marrow transplantation (BMT) by injection of bone marrow cells via portal vein: stromal cells as BMT-facilitating cells. Stem Cells 2001;19:144-150. (Pubitemid 32222239)
92. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K. Transplantation of bone marrow cells reduces CCl4 induced liver fibrosis in mice. Hepatology 2004;40:1304-1311.
93. Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, Xiang P. Bone-marrow derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 2005;11:3431-3440. (Pubitemid 40873250)
94. ClinicalTrials.gov. http://clinicaltrials.gov. Accessed April 2010.
95. Yannaki E, Anagnostopoulos A, Kapetanos D, Xagorari A, Iordanidis F, Batsis I, et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 2006;34:1583-1587.
96. Levicar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif 2008; 41(suppl 1):115-125.
97. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levicar N, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008;103:1952-1958.
98. Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J, et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc 2008;40:1140-1144.
99. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007;10:459-466. (Pubitemid 350001896)
100. Liu F, Pan X, Chen G, Jiang D, Cong X, Fei R, Wei L. Hematopoietic stem cells mobilized by granulocyte colony- stimulating factor partly contribute to liver graft regeneration after partial orthotopic liver transplantation. Liver Transpl 2006;12:1129-1137.
101. Piscaglia AC, Shupe TD, Oh SH, Gasbarrini A, Petersen BE. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007;133:619-631.
102. Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006;45:13-19.
103. Spahr L, Lambert JF, Rubbia-Brandt L, Chalandon Y, Frossard JL, Giostra E, Hadengue A. Granulocyte colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 2008;48:221-229.
104. Schroeder T. Imaging stem-cell-driven regeneration in mammals. Nature 2008;453:345-351.